A1324 - 3-fucosyllactose as a nutritive substance in infant formula products

Closes 23 Jul 2025

Opened 11 Jun 2025

Overview

FSANZ has assessed an application made by Glycom A/S to permit the voluntary addition of 3-fucosyllactose (3-FL), a human-identical milk oligosaccharide (HiMO) produced using a genetically modified source organism, Escherichia coli K-12 in infant formula products. FSANZ has prepared a draft food regulatory measure. 

FSANZ has provided public notification and welcomes your submission to assist with consideration of the application.

Consultation papers

The consultation documents and a copy of the application can be accessed from the A1324 webpage on the FSANZ website. Please read these documents before preparing your submission.

Why your views matter

FSANZ invites and welcomes public and stakeholder input into standard setting processes. Your views will help us ensure food standards continue to protect public health and safety while supporting an effective, transparent and accountable regulatory framework for industry and food authorities.

How to make a submission

The Consultation Hub is FSANZ's platform for public consultation. We have set up an online survey response form to assist you in completing your submission. Please refer to the consultation documents in preparing your submission. Once you begin, you can save your progress and complete your submission before the consultation closes on 23 July 2025 at 11:59pm Australian Eastern Standard Time (AEST).

Audiences

  • Anyone from any background

Interests

  • Client service delivery
  • Feedback